An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient’s blood, developed by Johns Hopkins Kimmel Cancer Center investigators, could help clinicians more quickly identify and determine if pancreatic cancer therapies are working.
After testing the method, called ARTEMIS-DELFI, in blood samples from patients participating in two large clinical trials of pancreatic cancer treatments, researchers found that it could be used to identify…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply